ATE181361T1 - Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie - Google Patents

Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie

Info

Publication number
ATE181361T1
ATE181361T1 AT95932544T AT95932544T ATE181361T1 AT E181361 T1 ATE181361 T1 AT E181361T1 AT 95932544 T AT95932544 T AT 95932544T AT 95932544 T AT95932544 T AT 95932544T AT E181361 T1 ATE181361 T1 AT E181361T1
Authority
AT
Austria
Prior art keywords
sickle cell
globin
composition
cell anemia
treating sickle
Prior art date
Application number
AT95932544T
Other languages
English (en)
Inventor
Philippe Leboulch
Irving M London
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE181361T1 publication Critical patent/ATE181361T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
AT95932544T 1994-09-19 1995-09-19 Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie ATE181361T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30879594A 1994-09-19 1994-09-19

Publications (1)

Publication Number Publication Date
ATE181361T1 true ATE181361T1 (de) 1999-07-15

Family

ID=23195426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932544T ATE181361T1 (de) 1994-09-19 1995-09-19 Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie

Country Status (8)

Country Link
US (2) US5861488A (de)
EP (1) EP0783575B1 (de)
JP (1) JPH10509027A (de)
AT (1) ATE181361T1 (de)
CA (1) CA2199832C (de)
DE (1) DE69510356D1 (de)
GR (1) GR3031229T3 (de)
WO (1) WO1996009385A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853975A (en) 1994-08-23 1998-12-29 Millennium Pharmaceuticals, Inc. Methods for identifying compositions for the treatment of body weight disorders, including obesity
WO1996009385A1 (en) * 1994-09-19 1996-03-28 Massachusetts Institute Of Technology Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
ES2348868T3 (es) 2002-12-13 2010-12-16 Genetix Pharmaceuticals Inc. Vectores retrovirales terapeuticos para terapia genica.
WO2010012002A1 (en) * 2008-07-25 2010-01-28 Saryna Medical Corporation Methods and systems for genetic analysis of fetal nucleated red blood cells
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
AU2011377617B2 (en) 2011-09-23 2018-03-08 Bluebird Bio, Inc. Improved gene therapy methods
CA2850484C (en) 2011-09-30 2021-01-26 Bluebird Bio, Inc. Compounds for improved viral transduction
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
WO2016039933A1 (en) 2014-09-11 2016-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lentiviral vector for treating hemoglobin disorders
WO2017059241A1 (en) 2015-10-02 2017-04-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lentiviral protein delivery system for rna-guided genome editing
KR20250134722A (ko) 2016-02-12 2025-09-11 블루버드 바이오, 인코포레이티드. Vcn 인핸서 조성물 및 이의 사용 방법
CN108883136A (zh) 2016-02-12 2018-11-23 蓝鸟生物公司 Vcn增强子组合物及其使用方法
US12110499B2 (en) 2017-04-24 2024-10-08 Seattle Children's Hospital Homology directed repair compositions for the treatment of hemoglobinopathies
WO2021094752A1 (en) 2019-11-12 2021-05-20 Oxford Biomedica (Uk) Limited Production system
EP4373951A1 (de) 2021-07-19 2024-05-29 2seventy bio, Inc. Vektorherstellungsverfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0377676B1 (de) * 1987-09-17 1995-05-24 Massachusetts Institute Of Technology Menschliche, erythroid-spezifische transkriptionsenhancer
US5239061A (en) * 1990-06-20 1993-08-24 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
US5631162A (en) * 1993-06-11 1997-05-20 Massachusetts Institute Of Technology Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
WO1995000657A1 (en) * 1993-06-21 1995-01-05 The Uab Research Foundation Anti-sickling hemoglobin
WO1996009385A1 (en) * 1994-09-19 1996-03-28 Massachusetts Institute Of Technology Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease

Also Published As

Publication number Publication date
CA2199832C (en) 2000-08-01
EP0783575A1 (de) 1997-07-16
CA2199832A1 (en) 1996-03-28
JPH10509027A (ja) 1998-09-08
US5861488A (en) 1999-01-19
WO1996009385A1 (en) 1996-03-28
US6051402A (en) 2000-04-18
EP0783575B1 (de) 1999-06-16
GR3031229T3 (en) 1999-12-31
DE69510356D1 (de) 1999-07-22

Similar Documents

Publication Publication Date Title
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69430990D1 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
EA200100502A1 (ru) СПОСОБЫ И КОМПОЗИЦИЯ ДЛЯ ВОССТАНОВЛЕНИЯ КОНФОРМАЦИОННОЙ СТАБИЛЬНОСТИ БЕЛКА СЕМЕЙСТВА p53
ATE257392T1 (de) Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen
NO963742L (no) Fremgangsmåte til å stimulere hematopoese med hemaglobin
DE69128893D1 (de) Genetische veränderung von endothelzellen
ATE209679T1 (de) Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
DE69927507D1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
ATE342278T1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69837491D1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
ATE59962T1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
DE69939937D1 (de) Translations-kontrollelemente für proteinexpression mit hoher ausbeute in den plastiden von höheren pflanzen und verfahren zu deren verwendung
ZA87141B (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
ES2113878T3 (es) Proteina c hibrida.
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE419348T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE3485773D1 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties